Suppr超能文献

LABS 队列中炎症和肥胖的血清生物标志物:与代谢性疾病和手术结果的关联。

Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes.

机构信息

Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.

Ann Arbor Veteran's Administration Hospital, Ann Arbor, MI, USA.

出版信息

Int J Obes (Lond). 2019 Feb;43(2):285-296. doi: 10.1038/s41366-018-0088-z. Epub 2018 May 17.

Abstract

BACKGROUND

The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined.

METHODS

Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP), cystatin C (CC), leptin, and ghrelin) with baseline measures of adiposity and metabolic disease prevalence (asthma, diabetes, sleep apnea), and weight loss and metabolic disease remission after bariatric surgery were studied in the Longitudinal Assessment of Bariatric Surgery (LABS) cohort.

RESULTS

Baseline CRP levels were positively associated with the odds of asthma but not diabetes or sleep apnea; baseline CC levels were positively associated with asthma, diabetes, and sleep apnea; baseline leptin levels were positively associated with asthma and negatively associated with diabetes and sleep apnea; baseline ghrelin levels were negatively associated with diabetes and sleep apnea. Increased weight loss was associated with increased baseline levels of leptin and CRP and decreased baseline levels of CC. Remission of diabetes and asthma was not associated with baseline levels of any biomarker. A higher likelihood of asthma remission was associated with a greater decrease in leptin levels, and a higher likelihood of diabetes remission was predicted by a lesser decrease in CC. Bariatric surgery was associated with decreased post-operative CC, CRP, and leptin levels, and increased post-operative ghrelin levels.

CONCLUSION

This is the largest study to date of serum biomarkers of inflammation and adiposity in a bariatric surgery cohort. Biomarker levels correlate with metabolic disease prevalence prior to bariatric surgery, and with weight loss but not metabolic disease remission after surgery. Bariatric surgery regulates serum biomarker levels in a manner consistent with anti-inflammatory and compensatory orexigenic effects. These data contribute to our understanding of the mechanisms underlying the biologic effects of bariatric surgery.

摘要

背景

与炎症和肥胖相关的血清生物标志物作为预测肥胖症手术前后代谢性疾病患病率和结局的指标,其效用尚未明确。

方法

在肥胖症手术纵向评估(LABS)队列中,研究了术前和术后四种生物标志物(C 反应蛋白(CRP)、胱抑素 C(CC)、瘦素和 ghrelin)血清水平与基线肥胖指标和代谢性疾病患病率(哮喘、糖尿病、睡眠呼吸暂停)以及肥胖症手术后体重减轻和代谢性疾病缓解之间的关联。

结果

基线 CRP 水平与哮喘的患病几率呈正相关,但与糖尿病或睡眠呼吸暂停无关;基线 CC 水平与哮喘、糖尿病和睡眠呼吸暂停呈正相关;基线瘦素水平与哮喘呈正相关,与糖尿病和睡眠呼吸暂停呈负相关;基线 ghrelin 水平与糖尿病和睡眠呼吸暂停呈负相关。体重减轻越多,基线瘦素和 CRP 水平越高,CC 水平越低。糖尿病和哮喘的缓解与任何生物标志物的基线水平均无关。哮喘缓解的可能性更高与瘦素水平的降低幅度更大有关,而糖尿病缓解的可能性更高与 CC 水平的降低幅度更小有关。肥胖症手术与术后 CC、CRP 和瘦素水平降低以及 ghrelin 水平升高有关。

结论

这是迄今为止肥胖症手术队列中炎症和肥胖相关血清生物标志物的最大规模研究。生物标志物水平与肥胖症手术前的代谢性疾病患病率相关,与手术后的体重减轻相关,但与代谢性疾病缓解无关。肥胖症手术以一种与抗炎和代偿性食欲刺激作用一致的方式调节血清生物标志物水平。这些数据有助于我们理解肥胖症手术生物学效应的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce7/6240401/3f11c53e60a1/nihms951090f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验